These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 19093186)
1. Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate. Goto Y; Katsumata N; Nakai S; Sasajima Y; Yonemori K; Kouno T; Shimizu C; Ando M; Fujiwara Y Int J Clin Oncol; 2008 Dec; 13(6):555-8. PubMed ID: 19093186 [TBL] [Abstract][Full Text] [Related]
2. Interventricular methotrexate therapy for carcinomatous meningitis due to breast cancer: a case with leukoencephalopathy. Hara H; Igarashi A; Yano Y; Yashiro T; Ueno E; Aiyoshi Y Breast Cancer; 2000; 7(3):247-51. PubMed ID: 11029806 [TBL] [Abstract][Full Text] [Related]
3. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. Chamberlain MC; Kormanik PA; Barba D J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977 [TBL] [Abstract][Full Text] [Related]
4. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis]. Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431 [TBL] [Abstract][Full Text] [Related]
5. [Three Cases of Intrathecal Chemotherapy with Ventricular Catheter for the Treatment of Leptomeningeal Metastasis from Breast Cancer]. Miyoshi K; Takahashi H; Uno M; Akai M; Moriyama E; Nakagawa T; Nomura T Gan To Kagaku Ryoho; 2018 Dec; 45(12):1767-1769. PubMed ID: 30587738 [TBL] [Abstract][Full Text] [Related]
6. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Boogerd W; van den Bent MJ; Koehler PJ; Heimans JJ; van der Sande JJ; Aaronson NK; Hart AA; Benraadt J; Vecht ChJ Eur J Cancer; 2004 Dec; 40(18):2726-33. PubMed ID: 15571954 [TBL] [Abstract][Full Text] [Related]
7. Current diagnosis and treatment of leptomeningeal metastasis. DeAngelis LM J Neurooncol; 1998; 38(2-3):245-52. PubMed ID: 9696379 [TBL] [Abstract][Full Text] [Related]
8. Prophylaxis and treatment of leptomeningeal carcinomatosis in solid tumors of adulthood. Hildebrand J J Neurooncol; 1998; 38(2-3):193-8. PubMed ID: 9696371 [TBL] [Abstract][Full Text] [Related]
9. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of leptomeningeal relapse of epithelial ovarian cancer. Gordon AN; Kavanagh JJ; Wharton JT; Rutledge FN; Obbens EA; Bodey GP Gynecol Oncol; 1984 May; 18(1):119-24. PubMed ID: 6714801 [TBL] [Abstract][Full Text] [Related]
11. [Case of leptomeningeal carcinomatosis effectively treated with intrathecal chemotherapy using ventriculoperitoneal shunt]. Miura M; Iijima N; Hayashida K; Kitazawa K; Ishii K; Ohara S Rinsho Shinkeigaku; 2006 Jun; 46(6):404-9. PubMed ID: 16986702 [TBL] [Abstract][Full Text] [Related]
12. Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Ongerboer de Visser BW; Somers R; Nooyen WH; van Heerde P; Hart AA; McVie JG Neurology; 1983 Dec; 33(12):1565-72. PubMed ID: 6685829 [TBL] [Abstract][Full Text] [Related]
13. [Intrathecal chemotherapy for leptomeningeal metastases in patients with breast cancer]. Moskvina EA; Belov DM; Naskhletashvili DR; Mekheda LV; Bekyashev AK; Aleshin VA; Gasparyan TG; Mitrofanov AA; Sevyan NV; Prozorenko EV; Tkhazeplov AA; Roshchina KE Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(3):31-37. PubMed ID: 38881013 [TBL] [Abstract][Full Text] [Related]
14. Case report and review of literature: leptomeningeal relapse in epithelial ovarian cancer. Khalil AM; Yamout BI; Tabbal SD; Salem ZM; Mroueh AM Gynecol Oncol; 1994 Aug; 54(2):227-31. PubMed ID: 8063252 [TBL] [Abstract][Full Text] [Related]
15. Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy. Clatot F; Philippin-Lauridant G; Ouvrier MJ; Nakry T; Laberge-Le-Couteulx S; Guillemet C; Veyret C; Blot E J Neurooncol; 2009 Dec; 95(3):421-426. PubMed ID: 19557501 [TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of meningeal carcinomatosis associated with primary lung cancer]. Yamamoto A; Takahashi K; Morio Y; Gunji Y; Iwakami N; Kajiyama Y; Yoshioka M; Miura K; Suzuki T; Ohwada A; Sato K; Fukuchi Y Nihon Kokyuki Gakkai Zasshi; 2005 Mar; 43(3):139-43. PubMed ID: 15801281 [TBL] [Abstract][Full Text] [Related]
17. Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease. Santa-Maria CA; Cimino-Mathews A; Moseley KF; Wolff AC; Blakeley JO; Connolly RM Clin Breast Cancer; 2012 Dec; 12(6):445-9. PubMed ID: 23010203 [No Abstract] [Full Text] [Related]
18. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy. Niwińska A; Rudnicka H; Murawska M Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959 [TBL] [Abstract][Full Text] [Related]